The United States Congress is close to approving new rules that will ease access to the US market for small Irish firms in the medical device sector.Companies with annual turnover of less than $100 million will be able to save up to $210,000 on applications to the Food and Drug Administration (FDA) to bring innovative new products to the US market.
